MUSC study to determine optimal dose of transcranial magnetic stimulation for MCI

FHS
July 29, 2023
12:01 am

With more than $3.7 million in funding from the National Institute on Aging, Medical University of South Carolina neuropsychologist Andreana Benitez, Ph.D., of the Department of Neurology in the College of Medicine will lead a phase II clinical trial to determine the optimal dose of transcranial magnetic stimulation, or TMS, needed to improve symptoms for patients with depression and mild cognitive impairment, or MCI.

Does parental mental health impact child school performance?

The relationship between parental mental disorders and child school performance.

September 7, 2023

Routine lab tests fail to detect long COVID in 10,000-person study

Dive Brief: A study of more than 10,000 people found no evidence that any of 25 routine laboratory tests can detect long COVID. The study,

August 16, 2024

Scrambler therapy: A new non-invasive treatment for chronic pain

A new review paper co-authored by two Johns Hopkins pain experts suggests that scrambler therapy, a noninvasive pain treatment, can yield significant relief for approximately

July 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.